{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:57:29Z","timestamp":1769277449625,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400085"],"award-info":[{"award-number":["81400085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370607"],"award-info":[{"award-number":["81370607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Medical University General Hospital funding","award":["303070401301"],"award-info":[{"award-number":["303070401301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12185-016-2061-8","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T05:09:31Z","timestamp":1470114571000},"page":"540-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Abnormal histone acetylation of CD8+ T cells in patients with severe aplastic anemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Weiwei","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonghong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"2061_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOH.0b013e3282fa7470","volume":"15","author":"NS Young","year":"2008","unstructured":"Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15:162\u20138.","journal-title":"Curr Opin Hematol."},{"key":"2061_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","volume":"147","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43\u201370.","journal-title":"Br J Haematol"},{"key":"2061_CR3","first-page":"3659","volume":"8","author":"M Zheng","year":"2015","unstructured":"Zheng M, Liu C, Fu R, Wang H, Wu Y, Li L, et al. Abnormal immunomodulatory ability on memory T cells in humans with severe aplastic anemia. Int J Clin Exp Pathol. 2015;8:3659\u201369.","journal-title":"Int J Clin Exp Pathol."},{"key":"2061_CR4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3892\/mmr.2014.2344","volume":"10","author":"L Xing","year":"2014","unstructured":"Xing L, Liu C, Fu R, Wang H, Wang J, Liu X, et al. CD8+ HLA-DR+ T cells are increased in patients with severe aplastic anemia. Mol Med Rep. 2014;10:1252\u20138.","journal-title":"Mol Med Rep."},{"key":"2061_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1359-6446(05)03691-3","volume":"11","author":"AG Inche","year":"2006","unstructured":"Inche AG, La Thangue NB. Chromatin control and cancer-drug discovery: realizing the promise. Drug Discov Today. 2006;11:97\u2013109.","journal-title":"Drug Discov Today."},{"key":"2061_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G Egger","year":"2004","unstructured":"Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457\u201363.","journal-title":"Nature"},{"key":"2061_CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gde.2006.02.015","volume":"16","author":"KP Nightingale","year":"2006","unstructured":"Nightingale KP, O\u2019Neill LP, Turner BM. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev. 2006;16:125\u201336.","journal-title":"Curr Opin Genet Dev"},{"key":"2061_CR8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/cr.2011.42","volume":"21","author":"M Yun","year":"2011","unstructured":"Yun M, Wu J, Workman JL, Li B. Readers of histone modifications. Cell Res. 2011;21:564\u201378.","journal-title":"Cell Res"},{"key":"2061_CR9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381\u201395.","journal-title":"Cell Res"},{"key":"2061_CR10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"JE Bolden","year":"2006","unstructured":"Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006;5:769\u201384.","journal-title":"Nat Rev Drug Discov."},{"key":"2061_CR11","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.18632\/oncotarget.2289","volume":"5","author":"M Kroesen","year":"2014","unstructured":"Kroesen M, Gielen P, Brok IC, Armandari I, Hoogerbrugge PM, Adema GJ. HDAC inhibitors and immunotherapy; a double edged sword? Oncotarget. 2014;5:6558\u201372.","journal-title":"Oncotarget"},{"key":"2061_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","volume":"983","author":"S Thiagalingam","year":"2003","unstructured":"Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci. 2003;983:84\u2013100.","journal-title":"Ann N Y Acad Sci"},{"key":"2061_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.biochem.70.1.81","volume":"70","author":"SY Roth","year":"2001","unstructured":"Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Ann Rev Biochem. 2001;70:81\u2013120.","journal-title":"Ann Rev Biochem."},{"key":"2061_CR14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJ Ruijter de","year":"2003","unstructured":"de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370:737\u201349.","journal-title":"Biochem J"},{"key":"2061_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","volume":"48","author":"BM Camitta","year":"1976","unstructured":"Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63\u201370.","journal-title":"Blood"},{"key":"2061_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2141.1988.tb02460.x","volume":"70","author":"A Bacigalupo","year":"1988","unstructured":"Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol. 1988;70:177\u201382.","journal-title":"Br J Haematol"},{"key":"2061_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng1531","volume":"37","author":"MF Fraga","year":"2005","unstructured":"Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37:391\u2013400.","journal-title":"Nat Genet"},{"key":"2061_CR18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2010.08301.x","volume":"150","author":"DA Moreno","year":"2010","unstructured":"Moreno DA, Scrideli CA, Cortez MA, de Paula Queiroz R, Valera ET, da Silva Silveira V, et al. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. Br J Haematol. 2010;150:665\u201373.","journal-title":"Br J Haematol"},{"key":"2061_CR19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4161\/epi.22674","volume":"7","author":"M Damme Van","year":"2012","unstructured":"Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L, et al. HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance. Epigenetics. 2012;7:1403\u201312.","journal-title":"Epigenetics."},{"key":"2061_CR20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1517\/14728221003796609","volume":"14","author":"H Adams","year":"2010","unstructured":"Adams H, Fritzsche FR, Dirnhofer S, Kristiansen G, Tzankov A. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin\u2019s lymphoma. Expert Opin Ther Targets. 2010;14:577\u201384.","journal-title":"Expert Opin Ther Targets."},{"key":"2061_CR21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000334577","volume":"81","author":"JC Wang","year":"2011","unstructured":"Wang JC, Kafeel MI, Avezbakiyev B, Chen C, Sun Y, Rathnasabapathy C, et al. Histone deacetylase in chronic lymphocytic leukemia. Oncology. 2011;81:325\u20139.","journal-title":"Oncology."},{"key":"2061_CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/icb.2011.94","volume":"90","author":"GR Leggatt","year":"2012","unstructured":"Leggatt GR, Gabrielli B. Histone deacetylase inhibitors in the generation of the anti-tumour immune response. Immunol Cell Biol. 2012;90:33\u20138.","journal-title":"Immunol Cell Biol"},{"key":"2061_CR23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1349-7006.2010.01559.x","volume":"101","author":"R Noro","year":"2010","unstructured":"Noro R, Miyanaga A, Minegishi Y, Okano T, Seike M, Soeno C, et al. Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU\/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1\/cip1) expression. Cancer Sci. 2010;101:1424\u201330.","journal-title":"Cancer Sci"},{"key":"2061_CR24","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.2337\/db08-0645","volume":"57","author":"F Miao","year":"2008","unstructured":"Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes. 2008;57:3189\u201398.","journal-title":"Diabetes"},{"key":"2061_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaut.2009.03.007","volume":"33","author":"A Hewagama","year":"2009","unstructured":"Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun. 2009;33:3\u201311.","journal-title":"J Autoimmun"},{"key":"2061_CR26","first-page":"804","volume":"35","author":"N Hu","year":"2008","unstructured":"Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W, et al. Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol. 2008;35:804\u201310.","journal-title":"J Rheumatol"},{"key":"2061_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","volume":"363","author":"MA Glozak","year":"2005","unstructured":"Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene. 2005;363:15\u201323.","journal-title":"Gene"},{"key":"2061_CR28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/epi.23115","volume":"8","author":"A Fern\u00e1ndez-S\u00e1nchez","year":"2013","unstructured":"Fern\u00e1ndez-S\u00e1nchez A, Baraga\u00f1o Raneros A, Carvajal Palao R, Sanz AB, Ortiz A, Ortega F, et al. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells. Epigenetics. 2013;8:66\u201378.","journal-title":"Epigenetics."},{"key":"2061_CR29","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.4049\/jimmunol.180.12.8102","volume":"180","author":"Y Araki","year":"2008","unstructured":"Araki Y, Fann M, Wersto R, Weng NP. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J Immunol. 2008;180:8102\u20138.","journal-title":"J Immunol."},{"key":"2061_CR30","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.4049\/jimmunol.180.8.5309","volume":"180","author":"A Chandele","year":"2008","unstructured":"Chandele A, Joshi NS, Zhu J, Paul WE, Leonard WJ, Kaech SM. Formation of IL-7R\u03b1high and IL-7R\u03b1low CD8 T cells during infection is regulated by the opposing functions of GABP\u03b1 and Gfi-1. J Immunol. 2008;180:5309\u201319.","journal-title":"J Immunol."},{"key":"2061_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12185-010-0761-z","volume":"93","author":"S Zonghong","year":"2011","unstructured":"Zonghong S, Meifeng T, Huaquan W, Limin X, Jun W, Rong F, et al. Circulating myeloid dendritic cells are increased in individuals with severe aplastic anemia. Int J Hematol. 2011;93:156\u201362.","journal-title":"Int J Hematol"},{"key":"2061_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/MCB.01245-07","volume":"28","author":"X Wang","year":"2008","unstructured":"Wang X, Hayes JJ. Acetylation mimics within individual core histone tail domains indicate distinct roles in regulating the stability of higher-order chromatin structure. Mol Cell Biol. 2008;28:227\u201336.","journal-title":"Mol Cell Biol"},{"key":"2061_CR33","doi-asserted-by":"crossref","first-page":"e110576","DOI":"10.1371\/journal.pone.0110576","volume":"9","author":"R Tschismarov","year":"2014","unstructured":"Tschismarov R, Firner S, Gil-Cruz C, G\u00f6schl L, Boucheron N, Steiner G, et al. HDAC1 controls CD8+ T cell homeostasis and antiviral response. PLoS One. 2014;9:e110576.","journal-title":"PLoS One"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2061-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-016-2061-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2061-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T17:12:07Z","timestamp":1600967527000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-016-2061-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1007\/s12185-016-2061-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]}}}